UC Berkeley’s robotics software developer Covariant hiked its overall funding to $147m in a round led by returning investor Index Ventures.

MIT spinout Iterative Scopes has now raised $43.5m altogether from investors including Eli Lilly and Johnson & Johnson.

4490 Ventures-backed Rentable has received $22.5m in its series B round.

MIT spinout Quaise has added $12m to its coffers, having previously collected seed funding from The Engine.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

The all-stock transaction is expected to close by the end of this year and will provide an exit to Qualcomm Ventures.

Several corporate investors have backed a series A5 round for the clean nuclear energy technology developer that leverages Oregon State University research.

A range of strategic investors have backed a series A5 round for the clean nuclear energy technology developer that leverages OSU research.

The fund received commitments from real estate firms Greystar, Realogy, AvalonBay Communities, Camden Property Trust, JBG Smith and Leading Real Estate Companies of the World.

The multi-corporate-backed biologic pill developer has listed on the Nasdaq Global Market, pricing the shares below their range.